PLD
33
3
DHI
40
3
ROST
70
2
C
85
3
HSIC
62
-3
MU
79
3
HBAN
82
2
O
35
4
F
58
2
TROW
61
2
MHK
50
2
SLG
37
6
DRI
64
4
VLO
40
-2
SPG
53
2
MMC
60
3
CRM
59
-11
FIS
73
11
CMI
73
-2
NEE
52
2
PLD
33
3
DHI
40
3
ROST
70
2
C
85
3
HSIC
62
-3
MU
79
3
HBAN
82
2
O
35
4
F
58
2
TROW
61
2
MHK
50
2
SLG
37
6
DRI
64
4
VLO
40
-2
SPG
53
2
MMC
60
3
CRM
59
-11
FIS
73
11
CMI
73
-2
NEE
52
2
Financhill
Back

Citius Pharmaceuticals, Inc. 10K Form

Sell
19

CTXR
Citius Pharmaceuticals, Inc.

Last Price:
$0.80
Seasonality Move:
23.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTXR News And Ratings

See the #1 stock for the next 7 days that we like better than CTXR

CTXR Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-17.6M
Price / Cash Flow: 0
Annual Sales: $3.74
Price / Book: 0.25

Profitability

EPS (TTM): -3.81490
Net Income (TTM): $-39.7M
Gross Margin: $-214.2K
Return on Equity: -56.5%
Return on Assets: -32.17%

Citius Pharmaceuticals, Inc. Earnings Forecast

Key Citius Pharmaceuticals, Inc. Financial Ratios

  • Per Share Earnings over the last 15 years have been positive in 7 years.

Citius Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CTXR
CUSIP: 17322U
Website: citiuspharma.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 0.62
Quick Ratio: 0.09

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0.26

CTXR Technical Analysis vs Fundamental Analysis

Sell
19
Citius Pharmaceuticals, Inc. (CTXR) is a Sell

Is Citius Pharmaceuticals, Inc. a Buy or a Sell?